Sign Up to like & get
recommendations!
0
Published in 2019 at "Scientific Reports"
DOI: 10.1038/s41598-019-42523-0
Abstract: Antisense oligonucleotide (AO)-mediated splice modulation has been established as a therapeutic approach for tackling genetic diseases. Recently, Exondys51, a drug that aims to correct splicing defects in the dystrophin gene was approved by the US…
read more here.
Keywords:
chemistry;
systematic evaluation;
antisense oligonucleotide;
oligonucleotide mediated ... See more keywords